- Masimo has received de novo authorization for a device designed to improve the monitoring of blood oxygen in certain situations.
- The device, ORi, is intended to support standard pulse oximetry by providing additional insights into patients with higher than normal oxygenation, a condition known as hyperoxia.
- Patients receiving supplemental oxygen can develop hyperoxia, raising the risk of tissue damage. Physicians have traditionally used blood draws that are analyzed to monitor the condition.
